24/7 Patient Assistance: 760-405-8205
24/7 Patient Assistance: 760-405-8205
Hospitals & Clinics
specialties & services
Dr. Peyton graduated the medical school from the University of Tennessee, where he also completed his residency and fellowship programs. He is both specialized and board certified in Oncology. Dr. Peyton has been in practice for more than 11 years and is affiliated with Saint Thomas - Midtown Hospital. During his career, he has also contributed to various publications of medical interest.
AetnaBlue Cross of CaliforniaBlue Shield of CaliforniaCignaFirst Health PPOHumanaMultiPlan
University of Tennessee
Medical School
University of Tennessee
Residency
University of Tennessee
Fellowship
American Board of Internal Medicine - Oncology
Saint Thomas - Midtown Hospital
Languages: English/Spanish
(615) 284-5555
2000 Church St
Nashville, Tennessee 37236 
A Phase II Study of FOLFOXIRI Plus Panitumumab Followed by Evaluation for Resection in Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases ...
Bendell, J. C.,Zakari, A.,Peyton, J. D.,Boccia, R.,Moskowitz, M.,Gian, V.,Lipman, A.,Waterhouse, D.,LoCicero, R.,Earwood, C.,Lane, C. M.,Meluch, A.; Oncologist. 2016 Feb 26.
See more >>
24 citations A Phase II Trial of Preoperative Concurrent Chemotherapy/Radiation Therapy Plus Bevacizumab/Erlotinib in the Treatment of Localized Esophageal Cancer.
Bendell, J. C., Meluch, A., Peyton, J., Rubin, M., Waterhouse, D., Webb, C., Burris, H. A., Hainsworth, J. D.; Clin Adv Hematol Oncol. 2012 Jul.
See more >>
17 citations A Randomized Phase II Trial of Pemetrexed/Gemcitabine/Bevacizumab or Pemetrexed/Carboplatin/Bevacizumab in the First-Line Treatment of Elderly Patients with Advanced N...
Spigel, D.R., Hainsworth, J.D., Shipley, D.L., Ervin, T.J., Kohler, P.C., Lubiner, E.T., Peyton, J.D., Waterhouse, D.M., Burris, H.A., Greco, F.A.; J Thorac Oncol. 2012 Jan.
See more >>